Definitive Contract 75N93023C00054
Award Date
9/30/23
Potential Completion Date
11/30/24
Potential Value
$300K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Lifetime Omics, Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Coconut Grove, FL 33133, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
3
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
SBIR Program Phase I Action
Primary Consortia Member
Not listed
Similar Awards
This is a $300,000 Firm Fixed Price contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Vitruvian Bio, LLC, a small disadvantaged woman-owned business. The contract is for a Small Business Innovation Research (SBIR) Phase I project to be completed by June 30, 2023. The award is associated with a larger SBIR solicitation that sought innovative research proposals from small businesses to...
This is a $299,408 SBIR Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Darwin Biosciences, Inc., a woman-owned small business. The contract is for the development of rapid diagnostic assays for self-monitoring of acute or rebound HIV-1 infection. As a Small Business Innovation Research (SBIR) award, this contract is set aside for small businesses. The contract has a firm fixed price structure and a period of performance...
This is a $299,208 firm fixed price contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian federal agency, to John Snow Labs Inc., a self-certified small disadvantaged business. The contract is for SBIR Topic 135, with a period of performance through September 4, 2025. The contract does not have a set-aside designation. As an SBIR (Small Business Innovation Research) contract, it is part of a larger SBIR program managed by NIAID to fund research and...
This $1,797,717.00 Small Business Innovation Research (SBIR) Phase I contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency under the National Institutes of Health (NIH), to Intralytix Inc., a biotechnology company specializing in bacteriophage-based products. The contract is for the development of a "Universal, Scalable Artificial Intelligence-Based Platform for Manufacturing High Titer Biopharmaceuticals", which aligns with...
This SBIR Phase I contract was awarded by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) to Intuitive Biosciences Inc. for $299,855. The contract is associated with the NIH and Centers for Disease Control and Prevention (CDC) SBIR solicitation seeking proposals across numerous technical topics to advance public health goals through medical technologies, diagnostics, vaccines, cell therapies and other...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Tolka.ai Inc. (doing business as Tolka AI Therapeutics), a for-profit small business. The contract, valued at $299,993.00, is for research and development efforts related to NIAID's mission needs and SBIR program objectives. The original solicitation included a variety of research topics,...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the National Cancer Institute (NCI), a civilian federal agency, to Mediomics LLC, a woman-owned small business. The contract is for the development of glycosylation-specific research under SBIR Topic 294, with a ceiling value of $148,569. SBIR contracts are set-aside for small businesses to engage in research and development for the government. This Phase I contract represents the initial research and feasibility...
This federal contract award, valued at $224,562.96, was made by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services' National Institutes of Health (NIH). The contract was awarded to Infotech Soft, Inc., a for-profit, woman-owned business, and is a Definitive Contract with a Firm Fixed Price. The work is to be performed in Miami, Florida and the contract has a completion date of July 31, 2018. This appears to be a Small...
This federal contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to Cellmic, LLC, a small business, in the amount of $224,661.00. The contract is for a TELE-MONITORING FOR INFECTIOUS DISEASES: A REMOTE SYSTEM FOR ASSESSING PATIENT PARAMETERS AND SPECIMEN ANALYSIS project under the SBIR Program Phase I. The contract is a Definitive Contract with a Firm Fixed Price pricing type and has an ultimate completion date of August 29, 2017. The...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a Small Business Innovation Research (SBIR) Phase II contract to Nowdiagnostics, Inc., a small disadvantaged business, for a multiplexed remote system for filovirus disease surveillance. The firm-fixed-price contract, with a potential value of $2,431,860.00, was awarded on September 20, 2018 and has a completion date of September 30, 2022....